Natesto FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved May 28, 2014)
Brand name: Natesto
Generic name: testosterone
Dosage form: Intranasal Gel
Previous Name: CompleoTRT
Company: Acerus Pharmaceuticals Corporation
Treatment for: Hypogonadism, Male
Natesto (testosterone) is a bioadhesive intranasal gel testosterone product for the treatment of male hypogonadism.
Development timeline for Natesto
| Date | Article |
|---|---|
| May 29, 2014 | Approval FDA Approves Natesto (testosterone) Nasal Gel to Treat Men with Low Testosterone |
| Jul 9, 2013 | United States Food and Drug Administration Accepts Trimel's NDA for CompleoTRT |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.